Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 2,965,160 | 2,460,560 | -504,600 | $555.32M | $505.05M | 16.61% | -$50.26M |
| Kymera Therapeutics, Inc.(KYMR) | 3,872,052 | 3,872,052 | 0 | $444.01M | $432.86M | 14.24% | -$11.15M |
| GH Research PLC(GHRS) | 8,650,158 | 8,650,158 | 0 | $232.52M | $203.11M | 6.68% | -$29.41M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 16,001,284 | 16,001,284 | 0 | $311.54M | $187.22M | 6.16% | -$124.33M |
| Xencor, Inc.(XNCR) | 7,133,720 | 6,227,034 | -906,686 | $114.85M | $155.36M | 5.11% | +$40.51M |
| Nektar Therapeutics(NKTR) | 2,391,075 | 2,134,007 | -257,068 | $166.92M | $129.20M | 4.25% | -$37.72M |
| Alkermes plcSHS(ALKS) | 2,154,704 | 2,847,100 | +692,396 | $112.90M | $115.36M | 3.79% | +$2.47M |
| Stoke Therapeutics, Inc.(STOK) | 2,547,557 | 3,608,968 | +1,061,411 | $83.36M | $93.83M | 3.09% | +$10.48M |
| Tyra Biosciences, Inc.(TYRA) | 1,476,196 | 4,215,886 | +2,739,690 | $47.15M | $92.20M | 3.03% | +$45.05M |
| Zymeworks Inc.(ZYME) | 3,649,142 | 3,464,142 | -185,000 | $95.39M | $91.77M | 3.02% | -$3.62M |
| Cullinan Therapeutics Inc | 5,750,683 | 5,750,683 | 0 | $104.72M | $88.27M | 2.90% | -$16.45M |
| Structure Therapeutics IncADS | 3,366,823 | 2,691,426 | -675,397 | $180.70M | $84.16M | 2.77% | -$96.54M |
| Palvella Therapeutics, Inc.(PVLA) | 672,789 | 607,149 | -65,640 | $102.82M | $83.74M | 2.75% | -$19.07M |
| Kura Oncology Inc | 8,445,769 | 6,690,108 | -1,755,661 | $92.65M | $71.65M | 2.36% | -$21.00M |
| Ac Immune SaSHS | 19,822,436 | 19,822,436 | 0 | $47.18M | $51.93M | 1.71% | +$4.76M |
| Monte Rosa Therapeutics Inc | 4,460,886 | 4,276,578 | -184,308 | $107.95M | $51.02M | 1.68% | -$56.93M |
| Entera Bio LtdSHS | 2,425,000 | 17,052,893 | +14,627,893 | $4.29M | $49.62M | 1.63% | +$45.33M |
| Olema Pharmaceuticals Inc | 5,295,893 | 5,295,893 | 0 | $66.25M | $45.76M | 1.51% | -$20.50M |
| Crescent Biopharma Inc. | 2,748,763 | 3,093,590 | +344,827 | $49.48M | $45.14M | 1.48% | -$4.34M |
| 4d Molecular Therapeutics In | 2,879,289 | 2,879,289 | 0 | $38.29M | $41.20M | 1.36% | +$2.91M |
| Immunocore Holdings plcADS(IMCR) | 1,294,463 | 1,230,909 | -63,554 | $41.10M | $37.28M | 1.23% | -$3.81M |
| Annexon Inc | 8,698,173 | 8,278,164 | -420,009 | $49.67M | $35.02M | 1.15% | -$14.65M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,056,027 | 407,226 | -648,801 | $123.63M | $34.81M | 1.15% | -$88.82M |
| Sagimet Biosciences IncCOM SER A | 2,500,000 | 3,500,000 | +1,000,000 | $19.32M | $34.58M | 1.14% | +$15.26M |
| Pyxis Oncology Inc | 0 | 11,826,140 | +11,826,140 | $0 | $27.55M | 0.91% | +$27.55M |
| Absci Corporation | 2,361,674 | 2,361,674 | 0 | $27.37M | $25.44M | 0.84% | -$1.94M |
| Invivyd Inc | 28,165,000 | 28,165,000 | 0 | $24.57M | $24.51M | 0.81% | -$64.8K |
| Anteris Technologies Global | 3,000,000 | 3,000,000 | 0 | $29.55M | $23.31M | 0.77% | -$6.24M |
| Foghorn Therapeutics Inc | 5,842,000 | 5,842,000 | 0 | $28.51M | $20.86M | 0.69% | -$7.65M |
| Sutro Biopharma Inc | 1,251,788 | 1,251,788 | 0 | $41.56M | $20.17M | 0.66% | -$21.39M |
| Q32 Bio Inc | 2,350,000 | 2,350,000 | 0 | $29.94M | $19.43M | 0.64% | -$10.50M |
| Alector Inc | 0 | 10,046,206 | +10,046,206 | $0 | $18.59M | 0.61% | +$18.59M |
| Eledon Pharmaceuticals Inc | 6,293,282 | 6,293,282 | 0 | $24.80M | $15.92M | 0.52% | -$8.87M |
| Disc Medicine, Inc.(IRON) | 1,153,612 | 233,300 | -920,312 | $84.38M | $15.27M | 0.50% | -$69.10M |
| Avalo Therapeutics Inc | 2,075,545 | 907,406 | -1,168,139 | $38.36M | $13.91M | 0.46% | -$24.45M |
| Onkure Therapeutics IncCL A | 3,235,778 | 4,045,278 | +809,500 | $14.76M | $11.02M | 0.36% | -$3.73M |
| Immunic Inc | 765,295 | 765,295 | 0 | $11.76M | $7.12M | 0.23% | -$4.65M |
| Tcgx Acquisition CorpCL A | 0 | 500,000 | +500,000 | $0 | $6.25M | 0.21% | +$6.25M |
| Research Alliance Corp IvCL A | 0 | 500,000 | +500,000 | $0 | $5.92M | 0.19% | +$5.92M |
| Research Alliance Corp IiiCL A | 500,000 | 500,000 | 0 | $5.35M | $5.36M | 0.18% | +$5.0K |
| Molecular Partners AgADS | 1,353,968 | 1,353,968 | 0 | $5.15M | $5.19M | 0.17% | +$40.6K |
| Imagenebio Inc | 1,110,002 | 1,110,002 | 0 | $6.55M | $5.08M | 0.17% | -$1.47M |
| X4 Pharmaceuticals Inc | 2,233,742 | 1,576,624 | -657,118 | $10.43M | $4.57M | 0.15% | -$5.86M |
| Inventiva SaADS | 686,040 | 686,040 | 0 | $2.59M | $2.53M | 0.08% | -$61.7K |
| Tscan Therapeutics Inc | 5,564,290 | 5,564,290 | 0 | $5.45M | $1.75M | 0.06% | -$3.70M |
| Engene Therapeutics IncW EXP 10 31 202 | 945,402 | 945,402 | 0 | $274.1K | $189.2K | 0.01% | -$84.9K |
| Tenax Therapeutics Inc | 339,549 | 25,000 | -314,549 | $4.94M | $47.3K | 0.00% | -$4.89M |
| Xoma Royalty Corporation | 7,593,303 | 0 | -7,593,303 | $322.72M | $0 | — | -$322.72M |